Trials / Unknown
UnknownNCT01886820
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 290 (estimated)
- Sponsor
- Navidea Biopharmaceuticals · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
To Determine the the Efficacy and Safety of \[18F\]NAV4694 PET for Detection of Cerebral β-Amyloid When Compared With Postmortem Histopathology
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [18F]NAV4694 |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2018-06-01
- Completion
- 2018-09-01
- First posted
- 2013-06-26
- Last updated
- 2017-07-26
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01886820. Inclusion in this directory is not an endorsement.